Sichuan Kelun-Biotech Plans Amendments to Corporate Structure
Company Announcements

Sichuan Kelun-Biotech Plans Amendments to Corporate Structure

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is set to propose amendments to its Articles of Association to reflect changes in its share capital structure and the newly amended Company Law of China. These amendments are pending approval from the company’s shareholders at the upcoming general meeting. Investors will be keen to see how these changes align with the company’s strategic direction and regulatory compliance.

For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App